tapebrief
MCHP · Q3 2026
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

MCHP · Q4 2026 Earnings

Microchip Technology

Reported May 7, 2026

30-second summary

Microchip delivered Q4 revenue of $1.311B (+35.1% YoY, +10.6% QoQ), beating both consensus ($1.26B) by 4.0% and the high end of the prior guide ($1.28B) by $31M, with non-GAAP EPS of $0.57 beating consensus by 14% and the guide high by $0.05. More important: the June guide of $1.442B–$1.469B implies +33.5% to +36.0% YoY and +11% QoQ — a steeper slope than March, anchored to distribution restocking that management said has now begun ("inventory now fully corrected actually to be below normal"). The recovery has cleanly transitioned from channel-correction mechanics to demand-driven acceleration, with gross margin guided to 62.25%–63.25% and the path to the 65% long-term target reframed as essentially achieved once underutilization charges normalize.

Headline numbers

EPS

Q4 FY2026

$0.57

+14.0% vs est.

Revenue

Q4 FY2026

$1.31B

+35.1% YoY

+4.0% vs est.

Gross margin

Q4 FY2026

61.6%

Free cash flow

Q4 FY2026

$0.24B

Operating margin

Q4 FY2026

30.6%

Key financials

Q4 FY2026
MetricQ4 FY2026YoYQ3 FY2026QoQ
Revenue$1.31B+35.1%$1.19B+10.5%
EPS$0.57—$0.44+29.5%
Gross margin61.6%—60.5%+110bps
Operating margin30.6%—28.5%+210bps
Free cash flow$0.24B—$0.32B-23.8%

Guidance

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
RevenueQ4 FY2026$1.24B to $1.28B$1.311B+$0.031B above high endBeat
Non-GAAP EPSQ4 FY2026$0.48 to $0.52$0.57+$0.05 above high endBeat
Non-GAAP Gross MarginQ4 FY202660.5% to 61.5%61.6%+0.1 points above high endBeat
Non-GAAP Operating MarginQ4 FY202628.8% to 30.2%30.6%+0.4 points above high endBeat
Sequential Revenue GrowthQ4 FY20266.2%10.6%+4.4 points above guideBeat
Year-over-Year Revenue GrowthQ4 FY202629.8%35.1%+5.3 points above guideBeat

New guidance

MetricPeriodGuideYoY
RevenueQ1 FY2027$1.442B to $1.469B+33.5% to +36.0% YoY
Non-GAAP EPSQ1 FY2027$0.67 to $0.71—
Non-GAAP Gross MarginQ1 FY202762.25% to 63.25%—
Non-GAAP Operating ExpenseQ1 FY202728.75% to 29.25%—
Non-GAAP Operating ProfitQ1 FY202733.00% to 34.50%—
Sequential Revenue GrowthQ1 FY202711% (±1%)—

Capacity & utilization

Q4 FY2026
SegmentQ4 FY2026
Days Inventory Outstanding185 days
Distributor Inventory26 days
Inventory Reduction (9-month)$320.9M reduction from Dec 2024 peak

Profitability

Q4 FY2026
SegmentQ4 FY2026
Gross Margin (Non-GAAP)61.6%
Operating Margin (Non-GAAP)30.6%
Free Cash Flow Margin18.5%
Cash Flow from Operations$257.0M

Other KPIs

Q4 FY2026
SegmentQ4 FY2026
Shareholder Dividends Paid (FY)$984.0M

Management tone

Defensive restructuring → recovery mechanics → broken seasonality promise → recovery vindicated → restocking-driven acceleration.

Three quarters ago management was bifurcating gross margin into "product margin" (67.4%) versus reported (56.7%) to defend the recovery narrative against ~10.8 points of inventory and underutilization drag. Last quarter that bifurcation became unnecessary as the reported number printed in the 60s on schedule. This quarter management took the next step: "If you take our underutilization and add it back, I think we get there [65% gross margin]." The signal: the long-term target is no longer aspirational — it's mechanically blocked by one identifiable cost bucket that's already in measured decline. The defensive framework from Q2 has fully inverted into a confidence framework.

The inventory and distribution narrative has crossed a clean inflection. Last quarter management said distribution inventory had "largely corrected" with the sell-in/sell-through gap at $11.7M (down from $52.9M). This quarter: "We have seen the distribution inventory now fully corrected actually to be below normal and are seeing some restocking orders from distribution... Distributors are also seeing their customers come back in droves." For the first time in this cycle, channel inventory is a positive tailwind rather than a closing drag — distributor days at 26 means future shipments must outpace sell-through. This is the structural transition the bull case has been pricing since Q1, now confirmed.

Supply commentary has hardened from a tentative-to-broadening progression. Two quarters ago constraints were "isolated to specific areas"; last quarter they were "starting to spread more broadly"; this quarter: "These challenges previously were isolated to very specific areas, but are now starting to spread more broadly... everything is basically full." The "everything" framing is new. Combined with the pricing posture — "we are trying very hard to really stay on the good side of the customers and not do an indiscriminate broad-based price increase... we have not increased our prices" — management is signaling latent pricing power they're choosing not to monetize broadly, which is itself a confidence statement. The PSP-repeat tail risk remains the unspoken counterweight.

The data center narrative has shifted from "well-positioned with Gen 6" to specific architectural framing around inference workloads. "We're now starting to see increases in agentic AI and inference-based workloads. And those require a significantly larger amount of access to components that are traditionally PCIe-based... we believe we're positioned to grow well with the market in the coming years as we see that become more of the predominant growth area." The progression across four quarters — competitive positioning claim → exclusivity at 3nm → three design wins → durable inference-driven growth — is the trajectory bulls have been mapping. The financial impact still arrives with June 2026 production ramp, not this print.

One genuine hedge survived. On September, management said "we're not willing to make a call yet on kind of percentage of revenue growth in September... things look good, but we're not willing to make a call yet." After breaking the "three above-seasonal quarters" promise in Q2, management is unwilling to make a similar forward commitment despite materially stronger underlying data. That restraint is the right read.

Recurring themes management leaned on this quarter:

Inventory correction cycle complete; restocking phase underwaySupply constraints broadening across wafer, substrate, and subcontracting capacityData center/agentic AI as durable growth driver replacing prior AI training focusMargin expansion trajectory toward 65% gross margin target as underutilization charges declineCustomer relationship repair translating into design win acceleration and share gainsLead time extension creating pricing tailwind without aggressive increases

Risks management surfaced:

Substrate supply tightness impacting data center business ramp; 12-month shelf life constraintWafer foundry constraints on 70-80% of process nodes despite increased allocationPotential for broader lead time extensions across all product lines in coming quartersSeptember quarter visibility limited; backlog strength but no formal growth guidanceAdvanced node capacity (3nm) capacity less than half of world demand

Answers to last quarter's watch list

March revenue print at or above the $1.26B midpoint — Revenue printed $1.311B, $51M above the midpoint and $31M above the high end of the prior guide. The +29.8% YoY narrative didn't just hold — it printed at +35.1%.
Resolved positively
June quarter sequential guide ≥5% — June guide is +11% sequential (±1%), more than double the 5% threshold and meaningfully above March's +6.2% guide. The recovery slope is steepening into the historically strongest quarter, the opposite of the flattening risk flagged.
Resolved positively
Gross margin reaches 61.5% (high end of March guide) and progress toward 65% long-term target — Gross margin printed 61.6%, just above the prior guide high. The June guide of 62.25%–63.25% is +65 to +165bps further QoQ. Management framed the path to 65% as essentially mechanical once underutilization normalizes ($46.6M last quarter, declining each quarter).
Resolved positively
PCIe Gen6 production revenue commentary and additional design-win disclosure — Management did not disclose new Gen6 customer names or bracket Gen6 revenue figures in the press release. The data center narrative was reframed around agentic AI/inference workloads as the durable demand driver rather than additional Gen6 design wins specifically. Production ramp timing of June 2026 unchanged.
Continue monitoring
Whether substrate and foundry constraints force price increases or backlog stretches — Constraints have broadened materially ("everything is basically full"). Management explicitly chose not to do an indiscriminate broad-based price increase to protect partner relationships, framing pricing as case-by-case. No acknowledgement of speculative ordering or order cancellability changes — the PSP-repeat tail risk has not surfaced as a disclosed concern.
Continue monitoring
Adjusted FCF coverage of dividend at run-rate — Q4 FCF of $243M annualizes to ~$972M, broadly covering FY26 dividends of $984M without seasonal benefit. FY26 FCF of $871M came in below dividends paid on a full-year basis, but the Q4 run-rate cleared the threshold. The "no more borrowing to fund the dividend" commitment held in Q4 and the trajectory is improving.
Resolved positively

What to watch into next quarter

June revenue print at or above the $1.4555B midpoint — anything below the low end ($1.442B) would break the steepening-slope narrative and call the +11% sequential guide credibility into question. A print in the upper half (above $1.456B) would suggest the August call sets up a September guide also at or above seasonal.

September guide commentary — does management commit to sequential growth or repeat the "not willing to make a call yet" hedge — management's restraint this quarter is defensible, but a repeated hedge in August despite three consecutive blow-out quarters would signal something below the surface. Sequential guide above +5% would confirm the recovery is durable into the second half.

Gross margin reaches 63.25% (high end of June guide) and underutilization charges fall below $35M — the path to 65% rests on continued underutilization decline. A June print at the low end (62.25%) combined with stalled underutilization improvement would suggest the easier gains are behind.

Inventory days progress toward 130–150 target — Q4 printed 185 days; management said it will come down "naturally" toward 130–150. A flat or rising day count in June would suggest the company is filling supply chain rather than burning physical inventory, raising shipment-versus-end-demand questions.

Whether broadening supply tightness forces a broad-based price increase or shifts customer order behavior — management's explicit decision NOT to raise prices broadly is a relationship-management choice that can reverse quickly if constraints worsen. Any acknowledgement of broad price increases, lead times extending beyond 12 weeks systemically, or non-cancellable backlog terms would re-open PSP-repeat risk.

Data center revenue disclosure or Gen6 production ramp commentary — June 2026 is the prior-stated Gen6 production-revenue start. Specific revenue brackets, named hyperscaler customers, or quantification of agentic AI/inference-driven design wins would validate the four-quarter escalation in framing.

Sources

  1. Microchip Technology Q4 FY2026 press release, exhibit 99.1, filed via SEC EDGAR — https://www.sec.gov/Archives/edgar/data/827054/000082705426000012/exhibit991q4fy26.htm
  2. Management commentary referenced from the Q4 FY2026 earnings call (Steve Sanghi, CEO; Eric Bjornholt, CFO; Brian McKerson on data center positioning).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.